Xeris Total Current Assets from 2010 to 2024

XERS Stock  USD 3.51  0.07  1.96%   
Xeris Pharmaceuticals Total Current Assets yearly trend continues to be comparatively stable with very little volatility. Total Current Assets will likely drop to about 132.6 M in 2024. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2016-12-31
Previous Quarter
170.3 M
Current Value
162.8 M
Quarterly Volatility
38.3 M
 
Covid
Check Xeris Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xeris Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 5 M, Depreciation And Amortization of 13.8 M or Interest Expense of 27.9 M, as well as many indicators such as Price To Sales Ratio of 1.88, Dividend Yield of 0.0 or Days Sales Outstanding of 154. Xeris financial statements analysis is a perfect complement when working with Xeris Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Xeris Pharmaceuticals Correlation against competitors.
For more information on how to buy Xeris Stock please use our How to Invest in Xeris Pharmaceuticals guide.

Latest Xeris Pharmaceuticals' Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Xeris Pharmaceuticals over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Xeris Pharmaceuticals' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xeris Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Xeris Total Current Assets Regression Statistics

Arithmetic Mean86,427,609
Geometric Mean66,525,721
Coefficient Of Variation71.95
Mean Deviation55,353,316
Median44,053,000
Standard Deviation62,184,286
Sample Variance3866.9T
Range153.6M
R-Value0.87
Mean Square Error1047.8T
R-Squared0.75
Significance0.000031
Slope12,028,996
Total Sum of Squares54136.4T

Xeris Total Current Assets History

2024132.6 M
2023156.3 M
2021186.8 M
2020152.2 M
201987.5 M
2018117.9 M
201744.1 M

About Xeris Pharmaceuticals Financial Statements

Xeris Pharmaceuticals shareholders use historical fundamental indicators, such as Total Current Assets, to determine how well the company is positioned to perform in the future. Although Xeris Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Xeris Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Xeris Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Assets156.3 M132.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xeris Stock Analysis

When running Xeris Pharmaceuticals' price analysis, check to measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.